Cerebrovascular Diseases : Impact Factor & More
eISSN: 1421-9786pISSN: 1015-9770
Share this on:
Key Metrics
CiteScore 
4.1
Impact Factor
< 5
SNIP
1.11
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Cerebrovascular Diseases
Cerebrovascular Diseases Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | KARGER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1991 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Cerebrovascular Diseases ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cerebrovascular Diseases
Disparities in Prehospital Stroke Care: Neighbourhood Socioeconomic Status and Delays in Hospital Presentation.
- 6 May 2026
- Cerebrovascular diseases (Basel, Switzerland)
Feasibility and challenges of ambulance-delivered blood pressure lowering in hyperacute stroke.
- 4 May 2026
- Cerebrovascular diseases (Basel, Switzerland)
Optimal definition of early neurological deterioration in thrombolysis-treated acute ischemic stroke: ENCHANTED study.
- 4 May 2026
- Cerebrovascular diseases (Basel, Switzerland)
Erratum
- 27 Apr 2026
- Cerebrovascular Diseases
Reply to the Letter to the Editor: Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease: Impact of Prolonged Observations of Indocyanine Green Videoangiography.
- 24 Apr 2026
- Cerebrovascular diseases (Basel, Switzerland)
Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study.
- 24 Apr 2026
- Cerebrovascular diseases (Basel, Switzerland)
Disparities in Prehospital Stroke Care: Neighbourhood Socioeconomic Status and Delays in Hospital Presentation.
- 6 May 2026
- Cerebrovascular diseases (Basel, Switzerland)
Feasibility and challenges of ambulance-delivered blood pressure lowering in hyperacute stroke.
- 4 May 2026
- Cerebrovascular diseases (Basel, Switzerland)
Optimal definition of early neurological deterioration in thrombolysis-treated acute ischemic stroke: ENCHANTED study.
- 4 May 2026
- Cerebrovascular diseases (Basel, Switzerland)
Erratum
- 27 Apr 2026
- Cerebrovascular Diseases
Reply to the Letter to the Editor: Intraoperative Cortical Indocyanine Green Extravasation as a Predictor of Cerebral Hyperperfusion following Direct Revascularization for Moyamoya Disease: Impact of Prolonged Observations of Indocyanine Green Videoangiography.
- 24 Apr 2026
- Cerebrovascular diseases (Basel, Switzerland)
Functional and Patient-reported Outcomes in the Atorvastatin versus Placebo Trial of Hemorrhagic Cerebral Cavernous Malformations: An Exploratory Study.
- 24 Apr 2026
- Cerebrovascular diseases (Basel, Switzerland)
FAQs on Cerebrovascular Diseases
How long has Cerebrovascular Diseases been actively publishing? 
What is the publishing frequency of Cerebrovascular Diseases?
How many articles did Cerebrovascular Diseases publish last year?
What is the eISSN & pISSN for Cerebrovascular Diseases?
What is Citescore for Cerebrovascular Diseases?
What is SNIP score for Cerebrovascular Diseases?
Who is the publisher of Cerebrovascular Diseases?
